MX366952B - Modulación de la inmunidad celular usando oligosacáridos de leche humana. - Google Patents
Modulación de la inmunidad celular usando oligosacáridos de leche humana.Info
- Publication number
- MX366952B MX366952B MX2014011694A MX2014011694A MX366952B MX 366952 B MX366952 B MX 366952B MX 2014011694 A MX2014011694 A MX 2014011694A MX 2014011694 A MX2014011694 A MX 2014011694A MX 366952 B MX366952 B MX 366952B
- Authority
- MX
- Mexico
- Prior art keywords
- human milk
- milk oligosaccharides
- methods
- mediated immunity
- modulating cell
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
- A23C9/206—Colostrum; Human milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Public Health (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pediatric Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere a una composición nutricional para usarse para mejorar la inmunidad celular en un individuo que necesita de la misma, la composición nutricional comprende un oligosacárido de leche humana sialilado y un oligosacárido de leche humana fucosilado en donde la composición nutricional reúne uno de los siguientes: a) un líquido que comprende de 0.001mg/mL a 20 mg/mL del oligosacárido de leche humana fucosilado, y b) un polvo que comprende 0.0005% en peso a 5% en peso del oligosacárido de leche humana sialilado y de 0.0005% en peso a 5% en peso del oligosacárido de leche humana fucosilado: en donde la composición nutricional comprende el oligosacárido de la leche humana sialilada en una cantidad suficiente para mejorar las respuestas mediadas de células T y el oligosacárido de la leche humana fucosilada en una cantidad suficiente para mejorar las respuestas reguladoras de células T.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261616230P | 2012-03-27 | 2012-03-27 | |
| PCT/US2013/030185 WO2013148134A1 (en) | 2012-03-27 | 2013-03-11 | Methods for modulating cell-mediated immunity using human milk oligosaccharides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2014011694A MX2014011694A (es) | 2015-01-22 |
| MX366952B true MX366952B (es) | 2019-07-31 |
Family
ID=47913620
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014011694A MX366952B (es) | 2012-03-27 | 2013-03-11 | Modulación de la inmunidad celular usando oligosacáridos de leche humana. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20150064220A1 (es) |
| EP (1) | EP2830712A1 (es) |
| CN (2) | CN104363962A (es) |
| CA (1) | CA2866313C (es) |
| HK (1) | HK1205970A1 (es) |
| MX (1) | MX366952B (es) |
| MY (1) | MY168661A (es) |
| PH (1) | PH12014502163A1 (es) |
| SG (1) | SG11201406022YA (es) |
| WO (1) | WO2013148134A1 (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2016005408A (es) * | 2013-11-15 | 2016-08-11 | Nestec Sa | Ficomposiciones para prevenir o tratar alergias en infantes a partir de o alimentados por madres no secretoras mediante el suministro de oligosacaridos fucosilados, particularmente entre los niños en riesgo o nacidos por cesarea. |
| EP2888950A1 (en) * | 2013-12-24 | 2015-07-01 | Abbott Laboratories | Methods for treating, preventing, or reducing neuroinflammation or cognitive impairment |
| WO2016014473A1 (en) * | 2014-07-21 | 2016-01-28 | Abbott Laboratories | Nutrient delivery system with human milk oligosaccharides |
| US11040049B2 (en) | 2014-10-29 | 2021-06-22 | Glycom A/S | Composition comprising HMSs/HMOs and use thereof |
| US11040050B2 (en) | 2014-10-29 | 2021-06-22 | Glycom A/S | Composition comprising HMSs/HMOs and use thereof |
| JP7182872B2 (ja) * | 2014-10-29 | 2022-12-05 | グリコム・アクティーゼルスカブ | 過敏性腸症候群の治療のための合成組成物および方法 |
| DK3277287T3 (da) | 2015-03-31 | 2024-01-08 | Glycom As | Blandinger af humane mælke-oligosaccharider, der omfatter 3 '-o-sialyllactose |
| ES2870973T3 (es) | 2015-06-09 | 2021-10-28 | Glycom As | Mezclas ternarias de 6'-SL, LNnT y LST c |
| US11524019B2 (en) | 2017-08-21 | 2022-12-13 | Glycom A/S | Synthetic composition for reducing allergy symptoms |
| US11304966B2 (en) | 2017-12-22 | 2022-04-19 | Glycom A/S | Composition comprising HMOs for preventing or reducing nociception |
| US11234992B2 (en) | 2018-02-28 | 2022-02-01 | The Regents Of The University Of California | Methods and therapies for treating atherosclerosis and/or hyperlipidemia using oligosaccharides |
| KR20210016557A (ko) * | 2018-05-31 | 2021-02-16 | 글리콤 에이/에스 | 자가면역 질환 치료를 위한 hmo 혼합물 |
| KR102147103B1 (ko) * | 2018-08-24 | 2020-08-24 | 주식회사 진켐 | 홍삼 추출물 및 시알릴락토스를 포함하는 면역 증강용 약학 조성물 |
| EP3883393B1 (en) * | 2019-06-04 | 2022-09-07 | N.V. Nutricia | Nutritional composition comprising 2'fucosyllactose and dietary butyrate |
| PT3979827T (pt) * | 2019-06-04 | 2023-09-05 | Nutricia Nv | Composição nutricional compreendendo 2'fucosilactose e 3'galactosilactose |
| CN114452296A (zh) * | 2021-11-30 | 2022-05-10 | 内蒙古伊利实业集团股份有限公司 | 用于改善免疫应答的母乳低聚糖组合物及其应用 |
| CN114177187A (zh) * | 2021-12-10 | 2022-03-15 | 西北大学 | 富含α2，6-唾液酸修饰的羊乳酸性游离寡糖在制备免疫调节药物或功能食品中的应用 |
| CN117158588A (zh) * | 2023-08-29 | 2023-12-05 | 大连医科大学 | 一种含有3'sl和两种乳杆菌的婴幼儿制剂及其应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE265207T1 (de) | 1997-02-21 | 2004-05-15 | Abbott Lab | Verwendung von mehrfach ungesättigten fettsäuren zur vorbeugung von nekrotizierender enterokolitis |
| US6365218B1 (en) | 2000-02-04 | 2002-04-02 | Abbott Laboratories | Pediatric formula and methods for providing nutrition and improving tolerance |
| US6811801B2 (en) | 2001-12-12 | 2004-11-02 | Abbott Laboratories | Methods and compositions for brightening the color of thermally processed nutritionals |
| BRPI0708701A2 (pt) * | 2006-03-10 | 2011-06-07 | Nutricia Nv | uso de um sacarìdeo não digerìvel solúvel em água |
| SI1920781T1 (sl) * | 2006-11-10 | 2015-07-31 | Glycotope Gmbh | Sestavki, ki obsegajo na Core-1 pozitiven mikroorganizem in njih uporaba za zdravljenje ali profilakso tumorjev |
| MY159076A (en) * | 2007-11-08 | 2016-12-15 | Nestec Sa | Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates |
| EP2072052A1 (en) * | 2007-12-17 | 2009-06-24 | Nestec S.A. | Prevention of opportunistic infections in immune-compromised subjects |
| RU2530641C2 (ru) * | 2009-07-15 | 2014-10-10 | Н.В. Нютрисиа | Фукозиллактоза в качестве неусвояемого олигосахарида, идентичного грудному молоку, с новой функциональной пользой |
| NL2004201C2 (en) * | 2010-02-05 | 2011-08-08 | Friesland Brands Bv | Use of sialyl oligosaccharides to modulate the immune system. |
| CA2798675A1 (en) * | 2010-06-01 | 2011-12-08 | Glycom A/S | Polymorphs of 2'-o-fucosyllactose and producing thereof |
| SG191799A1 (en) * | 2010-12-31 | 2013-08-30 | Abbott Lab | Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof |
-
2013
- 2013-03-11 CA CA2866313A patent/CA2866313C/en active Active
- 2013-03-11 MY MYPI2014002738A patent/MY168661A/en unknown
- 2013-03-11 MX MX2014011694A patent/MX366952B/es active IP Right Grant
- 2013-03-11 CN CN201380016517.3A patent/CN104363962A/zh active Pending
- 2013-03-11 WO PCT/US2013/030185 patent/WO2013148134A1/en active Application Filing
- 2013-03-11 SG SG11201406022YA patent/SG11201406022YA/en unknown
- 2013-03-11 EP EP13711247.0A patent/EP2830712A1/en not_active Withdrawn
- 2013-03-11 CN CN201910688383.9A patent/CN110301646A/zh active Pending
- 2013-03-11 US US14/387,871 patent/US20150064220A1/en active Pending
-
2014
- 2014-09-26 PH PH12014502163A patent/PH12014502163A1/en unknown
-
2015
- 2015-07-09 HK HK15106572.6A patent/HK1205970A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2014011694A (es) | 2015-01-22 |
| SG11201406022YA (en) | 2014-10-30 |
| CN110301646A (zh) | 2019-10-08 |
| CA2866313C (en) | 2017-11-28 |
| CN104363962A (zh) | 2015-02-18 |
| WO2013148134A1 (en) | 2013-10-03 |
| HK1205970A1 (en) | 2015-12-31 |
| CA2866313A1 (en) | 2013-10-03 |
| MY168661A (en) | 2018-11-28 |
| PH12014502163A1 (en) | 2014-12-10 |
| US20150064220A1 (en) | 2015-03-05 |
| EP2830712A1 (en) | 2015-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12014502163A1 (en) | Methods for modulating cell-mediated immunity using human milk oligosaccharides | |
| WO2016040369A3 (en) | HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS | |
| WO2015168379A3 (en) | Combination vaccine devices and methods of killing cancer cells | |
| UY33405A (es) | Composiciones y bebidas que comprenden nutrientes, vitaminas, azúcares, cisteína y/o productos de azúcar-cisteína | |
| IN2014KN02620A (es) | ||
| PH12015501101A1 (en) | Method for eliciting an immune response to an immunogen | |
| HK1219501A1 (zh) | 新型乳酸菌、以新型乳酸菌作為有效成分的天然免疫活化劑以及含有新型乳酸菌的飲食品 | |
| PT2829250T (pt) | Implante dentário, pilar, sistema de implante e conjunto de implantação | |
| SG10201900041VA (en) | Meningococcus vaccines | |
| EP3177286A4 (en) | Compositions and methods for physiological delivery using cannabidiol | |
| EP3193919A4 (en) | Immunogenic/therapeutic glycoconjugate compositions and uses thereof | |
| IL260327A (en) | Human milk products used before and after active treatment | |
| AU2018201444B2 (en) | High fat human milk products | |
| ZA201409433B (en) | Canned food products having one or more fillings | |
| PH12017500013A1 (en) | Compositions and methods for enhancing immunity | |
| EP2950790A4 (en) | Methods for maintaining or improving health, well-being and/or a physiological function in a subject | |
| MX2018007737A (es) | Suplementos masticables de fruta. | |
| WO2013121452A8 (en) | Product comprising glucomannan and chitosan for the treatment of gastroesophageal reflux disease | |
| IL270936A (en) | A factor, food and drug that improve brain activity through lipopolysaccharide | |
| PH12014502259A1 (en) | Association of beta-glucans and arabinoxylans | |
| EP2907533A4 (en) | PLUG, MEDICAL MODULE AND MEDICAL SYSTEM | |
| MX2015012124A (es) | Composiciones y metodos para dirigir n-acetilglucosamina transferasa o-enlazada y promover la sanacion de heridas. | |
| GB2508828B (en) | Stump planing device, system and methods | |
| GB201522153D0 (en) | Meningococcal infection and modified neisseria lactamica | |
| UA71085U (ru) | Препарат для повышения иммунного потенциала и антиоксидантной защиты у глубокостельных коров "имувит" |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |